Not exact matches
These findings allowed researchers to create a chimera virus: a mouse virus with a human viral gene that can
be used to test molecules that inhibit human LANA protein
in an
animal model of disease, treating not only human herpes virus infection but also its associated cancers.
Further studies
in animal models and patients (with altered TRPM7 channel function) have
been initiated,
in order to evaluate the efficacy and safety
of magnesium as a therapeutic for this
disease.
«Chronic inflammation
of the intestine
is thought to
be caused by abnormal interactions between gut microbes, intestinal epithelial cells and the immune system, but so far it has
been impossible to determine how each
of these factors contribute to the development
of intestinal bowel
disease,» said Hyun Jung Kim, Ph.D., former Wyss Technology Development Fellow and first author on the study, speaking about the limitations
of conventional
in vitro and
animal models of bacterial overgrowth and inflammation
of the intestines.
The study
of these highly unusual but devastating prion
diseases has to date
been thwarted by a lack
of animal models that faithfully mimic the
disease processes
in humans.
Next, Ubogu and his team looked at an
animal model of AIDP where they
were able to block CD11b early
in the
disease process.
These tools, coupled with
animal models of disease and with the latest methodologies
in genomics and proteomics,
are leading to vast amounts
of information about the nervous system under normal and pathologic conditions.
«We know that urate has neuroprotective properties
in animal models, and an unusual convergence
of human studies suggested its possible use as a
disease - modifying strategy
in Parkinson's; so the positive results
of this trial
are very encouraging.»
Neurologist Malcolm MacLeod
of the Centre for Clinical Brain Sciences at the University
of Edinburgh and his colleagues combed through papers reporting the efficacy
of drugs
in eight
animal disease models and checked whether the authors reported four measures that
are widely acknowledged to reduce the risk
of bias.
The journal provides cutting - edge research including results from
animal models that
are likely to apply to patients, studies
in human tissue that provide new information about therapies or
disease, and innovative reports
of drug discovery and development.
Schmidt says, «These people can test compounds or antibodies
in well - defined
animal models that
are representative
of a human
disease.»
Still, he says, other groups have arrived at opposing results regarding the role
of T cells
in the
disease,
in part, perhaps, because their
animal models aren't the same.
More work
is needed to determine whether the findings on rapamycin hold true
in animal models of Leigh syndrome and other neurodegenerative
diseases, and to ascertain how exactly rapamycin
is altering the metabolism
of the cells.
Most
animal studies
of the
disease are conducted with laboratory mice that have
been genetically engineered and bred to
model ALS, but for this research, investigators used rats with ALS because they more accurately portray the
disease's variable course
in humans.
His laboratory already has shown that by inhibiting calcium channels
in T - cells, they
were able to prevent T - cell activation
in animal models of autoimmune
diseases like multiple sclerosis and colitis.
«The next stage would
be to repeat the study
in primates, a more suitable
animal model where HIV infection induces
disease,
in order to further demonstrate elimination
of HIV - 1 DNA
in latently infected T cells and other sanctuary sites for HIV - 1, including brain cells,» Dr. Khalili said.
«If human organs on chips can
be shown to
be robust and consistently recapitulate complex human organ physiology and
disease phenotypes
in unrelated laboratories around the world, as suggested by early proof -
of - concept studies, then we will see them progressively replace one
animal model at a time.
The most important advancement
in medicine
in the last 25 years
was the development
of genetic
modeling in animals, enabling us to figure out how fundamental mechanisms
of physiology and
disease work, such as
in bone loss.
«Our work and that
of our colleagues on stress and CRF have
been mechanistically implicated
in Alzheimer's
disease, but agents that impact CRF signaling have not been carefully tested for therapeutic efficacy or long - term safety in animal models,» said the study's principal investigator and corresponding author Robert Rissman, PhD, assistant professor in the Department of Neurosciences and Biomarker Core Director for the Alzheimer's Disease Cooperative Study
disease, but agents that impact CRF signaling have not
been carefully tested for therapeutic efficacy or long - term safety
in animal models,» said the study's principal investigator and corresponding author Robert Rissman, PhD, assistant professor
in the Department
of Neurosciences and Biomarker Core Director for the Alzheimer's
Disease Cooperative Study
Disease Cooperative Study (ADCS).
«There
's a lot
of literature that points to chondrodystrophy
in dogs as an exciting
animal model for degenerative disc
disease in people,» said Bannasch, who also holds the Maxine Adler Endowed Chair
in Genetics.
They choose a
model, the K / BxN serum transfer
model,
in which
disease severity can
be precisely controlled, which allowed them to test the hydrogel
in animals with different degrees
of arthritis severity.
But this remarkable therapeutic benefit isn't limited to MS. Previous research
in animal models that mimic other
diseases suggest that certain forms
of amyloids can ease damage from strokes, traumatic brain injuries and even heart attacks.
DNA vaccines have
been studied
in animal models of viral, bacterial, and parasitic
disease, as well as
animal models of tumors.
Yet despite achieving some encouraging results
in animal models of MS, drugs that block the activity of TNF tend not work in patients with MS.. In fact, they usually make symptoms worse, and they may even have caused the disease in people predisposed to it, says Fugge
in animal models of MS, drugs that block the activity
of TNF tend not work
in patients with MS.. In fact, they usually make symptoms worse, and they may even have caused the disease in people predisposed to it, says Fugge
in patients with
MS..
In fact, they usually make symptoms worse, and they may even have caused the disease in people predisposed to it, says Fugge
In fact, they usually make symptoms worse, and they may even have caused the
disease in people predisposed to it, says Fugge
in people predisposed to it, says Fugger.
The discovery
was made by developing a mouse
model of the
disease that enabled researchers to track which
of 15 genetic groups — or subclones —
of myeloma cells spread beyond their initial site
in the
animals» hind legs.
«Large
animal models of human
disease, like cats,
are really helpful for determining what
's going to happen
in a child when you
're treating them,» Vite said.
The objective
of Kogenix
is to achieve the initial capital needed to advance
in the pre-clinical trials already
being conducted with
animal models of Alzheimer's
disease.
The finding, by researchers at the University
of Illinois at Chicago College
of Medicine,
was reported July 16 at the Alzheimer's Association International Conference
in Copenhagen by Mary Jo LaDu, who
in 2012 developed a transgenic mouse that
is now regarded as the best
animal model of the human
disease.
«The results
of the study
are truly promising, since we
were able to show for the first time that A2A adenosine receptor antagonists actually have very positive effects
in an
animal model simulating hallmark characteristics and progression
of the
disease.
Studying these symptoms earlier
in the
animal model gives researchers more time to monitor the progression
of the
disease as well as assess the efficacy
of potential therapeutics and to determine if and when the course
of the
disease could
be altered.
Experimental
animal models have
been used to investigate many aspects
of the clinical
disease such as the sex bias
in myocarditis where testosterones
in males promote autoimmunity
in the heart while estrogens
in females suppress virus infection and autoimmunity.
Professor Bruno D'Agostino from the University
of Naples said: «For many years, my research group has
been working on the role
of nociceptin
in the regulation
of airway responsiveness
in animal models, and it
is very interesting translating our results into clinic area regarding asthma, a
disease that
is forecast to grow over the next years.»
If the marriage
of stem cells and CRISPR follows a similar path, it might not
be long before pigs have enough Homo sapiens
in them not only to grow human hearts, lungs, livers, and kidneys for transplant but also to
model human
diseases more closely than current lab
animals do and to test experimental drugs.
Once this work
is completed, a second stage
is committed,
in which researchers
of I - Stem,
in collaboration with specialists
in animal models of diseases targeted by the therapeutic explore the effects
of experimental transplantation
of cells obtained laboratory.
Katherine W. Klinger, PhD, Senior Vice President for Genetics and Genomics at the Genzyme Corporation, and Assistant Clinical Professor
in the Department
of Pediatrics at the University
of Connecticut School
of Medicine suggested that for an orphan
disease it may
be necessary to use multiple
animal models in the preclinical research stage, because one
animal model may not fully recapitulate the human
disease.
The CRISPR - Cas technology generates specific
animal models of disease and
is transforming
model generation
in mice, rats, rabbits, and larger
animals.
Additionally, the inflammatory profile
of endometriosis
in this
animal model mirrors what has
been reported
in human
disease [35 - 37] making this an excellent parallel study for our currently reported data.
It
is also intended for post-docs and scientists already working
in certain
of these fields and who
are interested
in expanding their knowledge on the potential applications
of these new techniques to their
models or
in neighbouring pathophysiological
models of analysis
of genes or
diseases using genetically modified
animals.
In animal models of disease, iPSCs have
been used to treat sickle cell anemia, Parkinson's
disease, diabetes, spinal cord injuries, and heart failure.
Animal gait
is affected
in models of human disorders such as Parkinson's
Disease, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, spinal cord injury and many others.
Fallon said that
in addition to the value
of the findings themselves, the study demonstrates advances
in creating
animal models that can
be used more successfully
in mimicking the
disease in ALS research, which
is a key element
in driving new research and possible therapies.
At BPRC non-human primate (NHP)
models of infectious
diseases are available
in high quality, using purpose - bred and MHC - typed
animals.
Some evidence
of the involvement
of retinal tissue hypoxia has come from
in vivo measurements
in animal models of disease, though the onset
of hypoxia and the severity
of the insult have
been difficult to identify.
He also showed that DBSI could
be used to examine the development
of white matter inflammation
in patients with neurodegenerative
diseases and
in animal models of these
diseases.
If they removed the sequence, dubbed CNS2, Tregs became unstable and often morphed into killer T cells — the type
of cell they
are supposed to
be controlling — resulting
in autoimmune
disease in animal models.
Not only
were Miconazole and clobetasol able to stimulate the differentiation
of stem cells into mature oligodendrocytes, most importantly, these drugs stimulated the formation
of new insulation (myelin) and reversed
disease severity
in animal models of MS.. While not all adult tissues
in our body contain stem cells, this approach may change the way
MS is managed.
Background: Treatment with HMG - CoA reductase inhibitors («statins») has
been variably associated with a reduced risk
of Alzheimer's
disease (AD)
in epidemiologic studies and reduced amyloid - β (Aβ) deposition
in animal models of AD.
Now this latter element, it turns out that we have a real opportunity because as Dave Calkins and others have now demonstrated very beautifully
in animal models, and we even have very good data now
in humans;
in glaucoma there
's an injury that happens first, and it
's the death or loss
of the cell that happens later
in the
disease.
Other data with either gene - deficient
animals or with agonist reagents to 4 - 1BB have highlighted another aspect
of biology
in that a suppressive activity has
been observed, for example, where stimulating 4 - 1BB
in autoimmune
models of MS or rheumatoid arthritis inhibits
disease progression and pathology.
Both recent experience with immunotherapy for clearance
of Aβ
in AD, and their own (and Prothena's) experience with AS - clearing immunotherapies
in animal models, indicate that
in order to
be effective as
disease - modifying agents when administered alone, therapies that remove proteinaceous aggregates from the brain must
be initiated
in the early clinical or even preclinical stages
of the
disease, before the burden
of other forms
of aging damage becomes entrenched.
Studies
in experimental
animal models have now not only stressed the importance
of OX40 and OX40L for autoimmune and inflammatory
disease manifestations, but shown that inhibiting this interaction can
be useful therapeutically.